Obesity Treatment News - Latest Updates & Headlines
This drug may result in weight loss for 3 years in adults without diabetes
New Delhi, April 13: Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in adults with overweight or obesity who do not have diabetes, according to new research.
Eli Lilly launches Mounjaro in India for anti obesity treatment
New Delhi, March 20: Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 diabetes and obesity.
Once monthly injectables to become future therapeutic options for obesity: Report
New Delhi, Jan 12: From once-weekly subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), longer-acting candidates allowing once-monthly administration may become the next generation of obesity management drugs, according to a report.